Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cressey

Showing results (31-40 of 160) with videos related to

Pageof 16
Sort By:
British Journal of Clinical Pharmacology|April 5, 2012
Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adultsChonlaphat Sukasem, Tim R Cressey, Pattamawan Prapaithong, et al.
Virology Journal|April 16, 2021
Pilot evaluation of an enzymatic assay for rapid measurement of antiretroviral drug concentrationsAyokunle O Olanrewaju, Benjamin P Sullivan, Ashley R Bardon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 6, 2025
Pharmacokinetics, Safety, Efficacy and Acceptability of Daclatasvir Plus Sofosbuvir in Young Children With Chronic HCV InfectionAhmed N Farrag, Maggie M Abbassi, Nirmeen A Sabry, et al.
The Journal of Antimicrobial Chemotherapy|October 9, 2009
Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai womenSoranun Chantarangsu, Tim R Cressey, Surakameth Mahasirimongkol, et al.
Clinical Pharmacokinetics|August 7, 2020
Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIVAhizechukwu C Eke, Adeniyi Olagunju, Brookie M Best, et al.
Journal of the International AIDS Society|September 2, 2020
Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trialWipaporn Natalie Songtaweesin, Surinda Kawichai, Nittaya Phanuphak, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Nevirapine exposure with WHO pediatric weight band dosing: enhanced therapeutic concentrations predicted based on extensive international pharmacokinetic experienceMina Nikanjam, Desiré Kabamba, Tim R Cressey, et al.
Open Forum Infectious Diseases|September 10, 2025
Are Sex-Specific Cutoffs Needed With a Next-Generation Urine Tenofovir Lateral Flow Assay for Antiretroviral Adherence Monitoring?Xin Niu, Derin Sevenler, Sandy Dossantos, et al.
The Pediatric Infectious Disease Journal|July 29, 2021
Effective and Safe Daclatasvir Drug Exposures Predicted in Children Using Adult FormulationsTim R Cressey, Maggie Abbassi, Marc Lallemant, et al.
Journal of Virus Eradication|August 3, 2016
Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai childrenTorsak Bunupuradah, Passorn Punyahotra, Tim R Cressey, et al.
Pageof 16

Showing results (31-40 of 160) with videos related to

Sort By:
Pageof 16
British Journal of Clinical Pharmacology|April 5, 2012
Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adultsChonlaphat Sukasem, Tim R Cressey, Pattamawan Prapaithong, et al.
Virology Journal|April 16, 2021
Pilot evaluation of an enzymatic assay for rapid measurement of antiretroviral drug concentrationsAyokunle O Olanrewaju, Benjamin P Sullivan, Ashley R Bardon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 6, 2025
Pharmacokinetics, Safety, Efficacy and Acceptability of Daclatasvir Plus Sofosbuvir in Young Children With Chronic HCV InfectionAhmed N Farrag, Maggie M Abbassi, Nirmeen A Sabry, et al.
The Journal of Antimicrobial Chemotherapy|October 9, 2009
Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai womenSoranun Chantarangsu, Tim R Cressey, Surakameth Mahasirimongkol, et al.
Clinical Pharmacokinetics|August 7, 2020
Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIVAhizechukwu C Eke, Adeniyi Olagunju, Brookie M Best, et al.
Journal of the International AIDS Society|September 2, 2020
Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trialWipaporn Natalie Songtaweesin, Surinda Kawichai, Nittaya Phanuphak, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Nevirapine exposure with WHO pediatric weight band dosing: enhanced therapeutic concentrations predicted based on extensive international pharmacokinetic experienceMina Nikanjam, Desiré Kabamba, Tim R Cressey, et al.
Open Forum Infectious Diseases|September 10, 2025
Are Sex-Specific Cutoffs Needed With a Next-Generation Urine Tenofovir Lateral Flow Assay for Antiretroviral Adherence Monitoring?Xin Niu, Derin Sevenler, Sandy Dossantos, et al.
The Pediatric Infectious Disease Journal|July 29, 2021
Effective and Safe Daclatasvir Drug Exposures Predicted in Children Using Adult FormulationsTim R Cressey, Maggie Abbassi, Marc Lallemant, et al.
Journal of Virus Eradication|August 3, 2016
Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai childrenTorsak Bunupuradah, Passorn Punyahotra, Tim R Cressey, et al.
Pageof 16